在患有非T2炎症表型的喘患者中以生物标志物为指导的吸入性皮质类固醇的取消 - 一个随机对照试验研究协议
Christiane Hammershaimb Mosbech1, Nina Skavlan Godtfredsen2,3, Charlotte Suppli Ulrik2,3
1Department of Respiratory Medicine, Copenhagen University Hospital - Hvidovre, Kettegaard Allé 30, Hvidovre, Denmark. christiane.mosbech@regionh.dk.
BMC pulmonary medicine
|October 4, 2023
概括
本研究研究了在非T2喘患者中安全降低吸入性皮质类固醇 (ICS) 的方法. 生物标志物引导的ICS逐渐缩小可能允许控制喘,副作用较少.
科学领域:
- 肺部病理学 肺部病理学
- 过敏和免疫学 过敏和免疫学
- 临床试验 临床试验
背景情况:
- 非T2喘缺乏高2型炎症生物标志物.
- 吸入性皮质类固醇 (ICS) 是标准的,但具有副作用的风险,并且在低T2炎症中有效性降低.
- 目前的指导方针可能会导致非T2喘患者过度使用ICS治疗.
研究的目的:
- 评估非T2喘患者是否可以在逐渐缩小ICS时保持控制.
- 探索一种以生物标志物为指导,节省皮质类固醇的治疗方法.
- 为了减少非T2喘中的ICS负担和相关副作用.
主要方法:
- 前性,多中心,开放标签,随机对照试验.
- 110名非T2喘患者随机分配1:1进行标准护理或ICS逐渐减少.
- ICS剂量减少50%为8周,然后完全删除;主要终点是喘控制问卷 (ACQ) 的变化.
主要成果:
- 数据收集正在进行中;正在分析初级终点 (ACQ变化) 和二级终点 (血清皮质素,血液中乙酸氨基,FeNO,FEV1,中乙酸氨基).
- 由于失去喘控制而导致的学时间是关键的次要结果.
结论:
- 这项试验将提供关于非T2喘中ICS缩小可行性的关键数据.
- 这些发现旨在支持个性化治疗策略.
- 这项研究旨在使皮质类固醇节约疗法能够获得更好的患者结果.
相关概念视频
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
281
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
281
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
317
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
317
COPD: Management Using Bronchodilators and Corticosteroids
224
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
224
Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma: Pathogenesis and Management
425
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
425


